Citation Enhance - Citation Pro النشر العلمي ️️
4.32K subscribers
5 photos
5 links
Increasing and boosting #Citations and #H_Index
Enhancing scientific resume
Enhancing scientific #CV for #Apply, #study_abroad, #PhD
Contributing name included in #ISI, #Scopus, and #Google_Scholar articles
@Enhance_Admin
Download Telegram
Enhance your academic resume by participating in articles for applying, study migration, PhD, and the excellence visa NIW in the US with articles and increasing and Boosting citations and H-Index promotion 🧑🎓🧑

The strongest and most committed research group with 24-hour support

For information on conditions, message the ID below👇 Contact Admin for immediate consultation: 🆔 @Enhance_Admin
3😍1
🔥🔥
Researchers who are having trouble verifying their ResearchGate account due to not having a academic email, can contact the admin to resolve their issue.
More Details: 👇👇 @Enhance_Admin
2

Researchers who are having trouble verifying their Google Scholar account due to not having a academic email, can contact the admin to resolve their issue.

More Details: 👇👇 @Enhance_Admin
Please open Telegram to view this post
VIEW IN TELEGRAM
2👍1
⭐️⭐️AI-generated nonsense about rat with giant penis published by leading scientific journal

A scientific paper purporting to show the signalling pathway of sperm stem cells has met with widespread ridicule after it depicted a rodent with an anatomically eye-watering appendage and four giant testicles.

The creature, labelled “rat”, was also sitting upright in the manner of a squirrel, while the graphic was littered with nonsensical words such as “dissilced”, “testtomcels” and “senctolic”.

A cut-away image showed “sterrn cells” in a Petri dish being picked up with a spoon.

It appeared in the journal Frontiers in Cell and Development Biology this week alongside several other absurd graphics that had been generated by the AI tool Midjourney.

The paper, written by researchers at the Honghui Hospital in China, has since been retracted by the journal, which issued an apology and said it was working to “correct the record”.


🔇 Channel:
@CiteEnhancePro
4
This media is not supported in your browser
VIEW IN TELEGRAM
With this Chrome extension, you can ask questions about the article.

Select any section of the article you want, and click on Ask.

Download and install:
https://typeset.io/copilot-chrome-plugin

Channel:
@CiteEnhancePro

Admin:
@Enhance_Admin
Please open Telegram to view this post
VIEW IN TELEGRAM
3
Exciting Collaboration Opportunity for Researchers!

Are you looking to have research papers in high-ranking journals? Here’s your chance!

⭐️We’re offering a fantastic opportunity for researchers interested in publishing research papers. The process is straightforward – all you need to do is cover the publication fee.

⭐️If you're interested, please send me your google scholar Page directly at @Enhance_Admin. Let’s work together to make your research shine!

Contact me today!
Please open Telegram to view this post
VIEW IN TELEGRAM
11
Scopus SJR Q3; PubMed, Medline

Title: Enhanced Anticancer Activity of Paclitaxel through Folic Acid-Conjugated Nanoliposomes in Breast Cancer Cells

position 3:booked
position 4:
position 5:booked
position 6:booked

@Enhance_Admin

Telegram:
t.me/CiteEnhancePro
💯5
Scopus Q3
 
Status: Revision Received
Title:
 Scaffold-Based Drug Delivery in Oral Cancer Therapy: Advances, Challenges, and Translational Prospects
 
This article is suitable for the following majors and sub-majors:

Dentistry, Oral and Maxillofacial Medicine, Oral Pathology, Oral Oncology, Dental Biomaterials, Pharmaceutical Sciences, Pharmaceutics, Drug Delivery, Nanomedicine, Biomedical Engineering, Biomaterials Engineering, Tissue Engineering, Regenerative Medicine, Cancer Biology, Oncology, Molecular Medicine, Biotechnology, Medical Biotechnology, Polymer Science, Nanotechnology, Clinical Pharmacy, Translational Medicine, Experimental Medicine, Materials Science, Bioengineering, Oral Medicine, Head and Neck Oncology

position 1:
position 2:
position 3:
position 4:

 
@Enhance_Admin
 
Telegram: t.me/CiteEnhancePro
Please open Telegram to view this post
VIEW IN TELEGRAM
4